Successful rescue therapy with raltegravir (MK-0518) and etravirine (TMC125) in an HIV-infected patient failing all four classes of antiretroviral drugs

被引:7
作者
Di Biagio, Antonio [1 ]
Bruzzone, Bianca [2 ]
Rosso, Raffaella [1 ]
Vigano, Ottavia [3 ]
Icardi, Giancarlo [2 ]
Viscoli, Claudio [1 ]
Rusconi, Stefano [3 ]
机构
[1] Univ Genoa, Dept Infect Dis, San Martino Hosp, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Hlth Sci, San Martino Hosp, I-16132 Genoa, Italy
[3] Univ Milan, Dept Clin Sci, L Sacco Hosp Vialba, Milan, Italy
关键词
D O I
10.1089/apc.2007.0215
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:355 / 357
页数:3
相关论文
共 8 条
[1]   Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment [J].
Aquaro, Stefano ;
D'Arrigo, Roberta ;
Svicher, Valentina ;
Di Perri, Giovanni ;
Caputo, Sergio Lo ;
Visco-Comandini, Ubaldo ;
Santoro, Mario ;
Bertoli, Ada ;
Mazzotta, Francesco ;
Bonora, Stefano ;
Tozzi, Valerio ;
Bellagamba, Rita ;
Zaccarelli, Mauro ;
Narciso, Pasquale ;
Antinori, Andrea ;
Perno, Carlo Federico .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) :714-722
[2]   Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2:: a pooled subgroup analysis of data from two randomised trials [J].
Clotet, Bonaventura ;
Bellos, Nicholas ;
Molina, Jean-Michel ;
Cooper, David ;
Goffard, Jean-Chrostophe ;
Lazzarin, Adriano ;
Woehrmann, Andrej ;
Katlama, Christine ;
Wilkin, Timothy ;
Haubrich, Richard ;
Cohen, Calvin ;
Farthing, Charles ;
Jayaweera, Dushyantha ;
Markowitz, Martin ;
Ruane, Peter ;
Spinosa-Guzman, Sabrina ;
Lefebvre, Eric .
LANCET, 2007, 369 (9568) :1169-1178
[3]  
*DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1
[4]   Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial [J].
Grinsztejn, Beatriz ;
Nguyen, Bach-Yen ;
Katlama, Christine ;
Gatell, Jose M. ;
Lazzarin, Adriano ;
Vittecoq, Daniel ;
Gonzalez, Charles J. ;
Chen, Joshua ;
Harvey, Charlotte M. ;
Isaacs, Robin D. .
LANCET, 2007, 369 (9569) :1261-1269
[5]   Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug resistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials [J].
Hicks, Charles B. ;
Cahn, Pedro ;
Cooper, David A. ;
Walmsley, Sharon L. ;
Katlama, Christine ;
Clotet, Bonaventura ;
Lazzarin, Adriano ;
Johnson, Margaret A. ;
Neubacher, Dietmar ;
Mayers, Douglas ;
Valdez, Hernan .
LANCET, 2006, 368 (9534) :466-475
[6]  
Johnson Victoria A, 2007, Top HIV Med, V15, P119
[7]   Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial [J].
Madruga, Jose Valdez ;
Cahn, Pedro ;
Grinsztejn, Beatriz ;
Haubrich, Richard ;
Lalezari, Jacob ;
Mills, Anthony ;
Pialoux, Gilles ;
Wilkin, Timothy ;
Peeters, Monika ;
Vingerhoets, Johan ;
de Smedt, Goedele ;
Leopold, Lorant ;
Trefiglio, Roberto ;
Woodfall, Brion .
LANCET, 2007, 370 (9581) :29-38
[8]   Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors [J].
Poveda, Eva ;
De Mendoza, Carmen ;
Martin-Carbonero, Luz ;
Corral, Angelica ;
Briz, Veronica ;
Gonzalez-Lahoz, Juan ;
Soriano, Vincent .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (04) :885-888